Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients-Reference-Cited by-同舟云学术

Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients

Published:2003-06 Issue:6 Volume:94 Page:548-556
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Mine Takashi,Gouhara Rumi,Hida Naoya,Imai Nobue,Azuma Kouichi,Rikimaru Touru,Katagiri Kazuko,Nishikori Misa,Sukehiro Aki,Nakagawa Masami,Yamada Akira,Aizawa Hisamichi,Shirouzu Kazuo,Itoh Kyogo,Yamana Hideaki

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2003.tb01481.x/fullpdf

Reference31 articles.

1. A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

2. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

3. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

4. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

5. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TC2N;European Journal of Microbiology and Immunology;2024-02-23

2. Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review;Vaccines;2023-01-09

3. IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides;Oncology Reports;2018-03-01

4. Antigen presentation of the Oct4 and Sox2 peptides by CD154-activated B lymphocytes enhances the killing effect of cytotoxic T lymphocytes on tumor stem-like cells derived from cisplatin-resistant lung cancer cells;Journal of Cancer;2018

5. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma;World Journal of Gastroenterology;2017